
Raj R Makkar MD
Interventional Cardiology
Vice President, Cardiovascular Innovation and Intervention; Associate Director of the Smidt Heart Institute for Interventional Technologies; Executive Director of Cardiac Interventional Services; Director of Interventional Cardiology Division; Director of the Interventional Cardiology Research Program
Join to View Full Profile
8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-423-3977
Fax+1 310-423-0106
Dr. Makkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Cedars-Sinai Medical CenterFellowship, Interventional Cardiology, 1996 - 1997
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
- Wayne State University School of MedicineResidency, Internal Medicine, 1990 - 1993
- KM School of PG Medicine and ResearchResidency, 1987 - 1990
- Gujurat UniversityMB, BS, 1981 - 1987
- N.H.L Municipal Medical CollegeClass of 1987
Certifications & Licensure
- CA State Medical License 1993 - 2027
- MI State Medical License 1993 - 1994
- American Board of Internal Medicine Interventional Cardiology
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Heart Disease of the Small Arteries in Women and Men Start of enrollment: 2005 Nov 01
- Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction Start of enrollment: 2005 Jul 01
- Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Start of enrollment: 2012 Nov 13
- Join now to see all
Publications & Presentations
PubMed
- Implications of an off-hours setting in patients undergoing transcatheter edge-to-edge repair for mitral regurgitation.Alon Shechter, Aakriti Gupta, Danon Kaewkes, Homa Taheri, Takashi Nagasaka
American Heart Journal. 2025-04-01 - Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial.Brian R Lindman, Philippe Pibarot, Allan Schwartz, J Bradley Oldemeyer, Yan Ru Su
Circulation. 2025-03-31 - Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.Saibal Kar, Raj R Makkar, Brian K Whisenant, Nadira Hamid, Hursh Naik
Circulation. 2025-03-30
Journal Articles
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveBrian Whisenant, Samir R Kapadia, Mackram F Eleid, James M Mccabe, Amar Krishnaswamy, Richard W Smalling, Charanjit S Rihal, Raj R Makkar, JAMA Cardiology
- Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER TrialEugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Martin B Leon, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensso..., ScienceDirect
- Clinical Research Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and Its Imp...Raj Makkar, MD, ScienceDirect
- Join now to see all
Lectures
- Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural OutcomesCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic ValvesCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Prevention and Management of Bioprosthetic Valve ThrombosisCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Join now to see all
Authored Content
- Impact of Pulmonary Artery Dilatation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementNovember 2021
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves PARTNER 3 Cardiac Computed Tomography SubstudyJune 2020
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves PARTNER 3 Cardiac Computed Tomography SubstudyJune 2020
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves PARTNER 3 Cardiac Computed Tomography SubstudyJune 2020
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves PARTNER 3 Cardiac Computed Tomography SubstudyJune 2020
- Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve ReplacementJanuary 2020
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- Join now to see all
Press Mentions
- JenaValve’s Trilogy THV Evaluated in Expanded Cohort of ALIGN-AR Pivotal TrialApril 7th, 2025
- JenaValve’s Trilogy THV Evaluated in Expanded Cohort of ALIGN-AR Pivotal TrialApril 7th, 2025
- Trilogy Valve Demonstrates Safety and Effectiveness in Treating Aortic RegurgitationMarch 30th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: